MK
GILD icon

MASTERINVEST Kapitalanlage’s Gilead Sciences GILD Stock Holding History

MASTERINVEST Kapitalanlage’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Sell
25,094
-260
-1% -$34.3K 0.27% 86
2026
Q1 		$3.53M Buy
25,354
+2,965
+13% +$415K 0.37% 65
2025
Q4 		$2.76M Buy
22,389
+1,224
+6% +$149K 0.26% 92
2025
Q3 		$2.35M Sell
21,165
-6,698
-24% -$761K 0.23% 104
2025
Q2 		$3.09M Buy
+27,863
New +$2.97M 0.32% 75

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MASTERINVEST Kapitalanlage's GILD Position: Q2 2026 in Review

MASTERINVEST Kapitalanlage reduced its Gilead Sciences (GILD) stake by 1% in Q2 2026, selling an estimated $34.3K and leaving 25,094 shares worth $3.17M. The position accounts for 0.27% of the portfolio, ranked #86.

MASTERINVEST Kapitalanlage first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.53M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • MASTERINVEST Kapitalanlage held 25,094 shares of Gilead Sciences worth $3.17M as of Q2 2026.
  • MASTERINVEST Kapitalanlage sold 260 Gilead Sciences shares in Q2 2026, an estimated $34.3K.
  • Gilead Sciences made up 0.27% of MASTERINVEST Kapitalanlage's portfolio in Q2 2026, its #86 holding.
  • MASTERINVEST Kapitalanlage first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • MASTERINVEST Kapitalanlage's Gilead Sciences position peaked at $3.53M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q2 2026, filed 17 Aug 2026.